Financhill
Back

Roper Technologies, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Sell
41

ROP
Roper Technologies, Inc.

Last Price:
$445.69
Seasonality Move:
4.88%
Buy
77

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.09
Seasonality Move:
9.28%
Sell
41
Roper Technologies, Inc. (ROP) is a Sell

Is Roper Technologies, Inc. a Buy, Sell or Hold?

  • The current Roper Technologies, Inc. [ROP] share price is $442.28. The Score for ROP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ROP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.19. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ROP Stock Price Chart

What is Roper Technologies, Inc.'s stock price today?

  • The Roper Technologies, Inc. share price today is $442.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ROP is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.

ROP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.57 Sell
Relative Strength Index (14 RSI): 39.94 Sell
Chaikin Money Flow: 16620 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 22.82 Buy
Relative Strength Index (14 RSI): 85.91 Buy
Chaikin Money Flow: 334557 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (142.93 - 241.17) Buy
Bollinger Bands (100): (50.82 - 164.58) Buy

ROP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 444.45 Sell
20-day SMA: 445.2 Sell
50-day SMA: 467.34 Sell
200-day SMA: 532.17 Sell
8-day EMA: 444.1 Sell
20-day EMA: 447.28 Sell
50-day EMA: 464.52 Sell
200-day EMA: 513.1 Sell

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.24 Sell
20-day SMA: 213.95 Buy
50-day SMA: 147.6 Buy
200-day SMA: 67.86 Buy
8-day EMA: 219.1 Buy
20-day EMA: 202.41 Buy
50-day EMA: 160.57 Buy
200-day EMA: 86.75 Buy

Roper Technologies, Inc. Earnings Growth & ROP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.69 per share, and an increase next year of $1.68 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Roper Technologies, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):